Replication study and meta-analysis in European samples supports association of the 3p21.1 locus with bipolar disorder.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Andreassen, Ole A
Diaconu, Carmen C
Czerski, Piotr M
Abramova, Lilia I
Mühleisen, Thomas W
Nöthen, Markus M
St Clair, David
Pietiläinen, Olli P H
Ophoff, Roel A
Børglum, Anders D
Mortensen, Preben B
Hollegaard, Mads V
van Winkel, Ruud
De Hert, Marc
Réthelyi, János M
Rubino, I Alex
Kiemeney, Lambertus A
van den Berg, Leonard H
Jönsson, Erik G
Collier, David A
MetadataShow full item record
CitationBiol. Psychiatry 2012, 72(8):645-50
AbstractCommon genetic polymorphisms at chromosome 3p21.1, including rs2251219 in polybromo 1 (PBRM1), have been implicated in susceptibility to bipolar affective disorder (BP) through genome-wide association studies. Subsequent studies have suggested that this is also a risk locus for other psychiatric phenotypes, including major depression and schizophrenia. To replicate the association, we studied 2562 cases with BP and 25,439 control subjects collected from seven cohorts with either genome-wide association or individual genotyping of rs2251219 and tagging single nucleotide polymorphisms across the PBRM1 gene. Results from the different case-control groups were combined with the inverse variance weighting method. In our dataset, rs2251219 was associated with BP (odds ratio [OR] = .89, p = .003), and meta-analysis of previously published data with our nonoverlapping new data confirmed genome-wide significant association (OR = .875, p = 2.68 × 10(-9)). Genotypic data from the SGENE-plus consortium were used to examine the association of the same variant with schizophrenia in an overall sample of 8794 cases and 25,457 control subjects, but this was not statistically significant (OR = .97, p = .21). There is strong evidence of association of rs2251219 with BP. However, our data do not support association of this marker with schizophrenia. Because the region of association has high linkage disequilibrium, forming a large haplotype block across many genes, it is not clear which gene is causally implicated in the disorder.
DescriptionTo access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to Biological psychiatry
- Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis.
- Authors: Kishi T, Okochi T, Tsunoka T, Okumura T, Kitajima T, Kawashima K, Yamanouchi Y, Kinoshita Y, Naitoh H, Inada T, Kunugi H, Kato T, Yoshikawa T, Ujike H, Ozaki N, Iwata N
- Issue date: 2011 Jan 30
- Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population.
- Authors: Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R, Van Broeckhoven C, Del-Favero J
- Issue date: 2006 Oct
- The genome-wide risk alleles for psychiatric disorders at 3p21.1 show convergent effects on mRNA expression, cognitive function, and mushroom dendritic spine.
- Authors: Yang Z, Zhou D, Li H, Cai X, Liu W, Wang L, Chang H, Li M, Xiao X
- Issue date: 2020 Jan
- BDNF gene is a risk factor for schizophrenia in a Scottish population.
- Authors: Neves-Pereira M, Cheung JK, Pasdar A, Zhang F, Breen G, Yates P, Sinclair M, Crombie C, Walker N, St Clair DM
- Issue date: 2005 Feb
- Evidence for the involvement of the glucocorticoid receptor gene in bipolar disorder in an isolated northern Swedish population.
- Authors: Ceulemans S, De Zutter S, Heyrman L, Norrback KF, Nordin A, Nilsson LG, Adolfsson R, Del-Favero J, Claes S
- Issue date: 2011 Nov-Dec